Edwards Lifesciences Corporation

Edwards Lifesciences to Sell LifeStent Product Line to Bard

Published in Medical Devices and Surgical Technology Week, December 30th, 2007

Edwards Lifesciences Corporation (NYSE:EW), a world leader in products and technologies to treat advanced cardiovascular disease, announced that it has entered into a definitive agreement to sell certain assets related to the Edwards LifeStent peripheral vascular product line to C.R. Bard, Inc. for up to $140 million. The transaction is expected to close in January 2008, pending regulatory approvals.

"Although sales are growing, the LifeStent product line is generating operating losses," said Michael A. Mussallem, Edwards Lifesciences' chairman and CEO. "This transaction enables Edwards to increase our investments in the exciting opportunities in our market-leading...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week

Source: Medical Devices and Surgical Technology Week (2007-12-30)

More Articles from Medical Devices and Surgical Technology Week

Obesity and Diabetes
Study suggests link between obesity, poor bone health
Obesity and Diabetes
UT Southwestern: Patients with mild Cushing syndrome may benefit from adrenalectomy
Back Pain
Special Report Describes a Medical Device That is Changing the Lives of Back Pain Sufferers
DNA Research
Major Advance in the Observation of DNA Molecules
Adenoidectomy
Studies from P. Oflyinn and colleagues yield new information about adenoidectomy
Algorithms
New algorithms research reported from W. Kristanto and co-authors
More from this issue of Medical Devices and Surgical Technology Week

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry